SMAD3 and neoplasm: Concurrently, Smad3—a tumor suppressor that enforces G1 arrest—is functionally inactivated in resistance models through CDK2-cyclin E-mediated phosphorylation, bypassing Rb-E2F suppression to restore cell cycle progression (Heldin and AJJoCS, 2005).